Do you want to read an article? Please log in or register.
Systemic Thromboembolic Outcomes in Young Patients Following Retinal Vein Occlusions
Retinal Diseases
Related content
Retinal Diseases
Treatment Patterns and Long-Term Outcomes with Anti-VEGF Therapy for Retinal Vein Occlusion: An Analysis of the Vestrum Database
Ophthalmol Retina
Ip M, Modi Y, Fekrat S, Gibson K, Boucher N, Arrisi P, Ishii F, Liu Y, Paris LP, Fenech M, Chi GC
doi: 10.1016/j.oret.2025.05.025
Retinal Diseases
Retinal Displacement Following Vitrectomy for Rhegmatogenous Retinal Detachment: A Systematic Review of Surgical Techniques, Tamponade Agents, and Outcomes
J Clin Med
Siwik P, Chudoba T, Cisiecki S
doi: 10.3390/jcm14010250
RECOMMENDED
Retinal Diseases
Is there an association between retinal vein occlusion and cerebrovascular accident? A systematic review and meta-analysis
★ 2
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
BMC Ophthalmol
Chen KY, Chan HC, Chan CM
doi: 10.1186/s12886-025-03944-w
COMMENTED
Retinal Diseases
Trends in the Incidence of Retinal Artery and Vein Occlusion Before and After COVID-19: A National Study in South Korea (2017-2022)
★ 2
Recommended and commented by
Prof. emer. Dr Josef Flammer, Faculty Member
Am J Ophthalmol
Cho J, Lee NK, Kim JY, Lee CS, Byeon SH, Kim SS, Lee SW, Kim YJ
doi: 10.1016/j.ajo.2025.03.005
Retinal Diseases
Integration of Proteomics and Artificial Intelligence-Driven OCT Biomarker Analysis in Central Vein Retinal Occlusion
Exp Eye Res
Desideri LF, Kojima K, Eldridge N, Zysset-Burri DC, Ørskov M, Vorum H, Honoré B, Zinkernagel MS, Cehofski LJ
doi: 10.1016/j.exer.2025.110462
Macular DiseasesRetinal Diseases
Predicting Treatment Response in Retinal Vein Occlusions Using Baseline Optical Coherence Tomography Biomarkers: A Systematic Review
Surv Ophthalmol
Hatamnejad A, Nanji K, Grad J, El-Sayes A, Mihalache A, Gemae M, Huang R, Waheed NK, Sarraf D, Sadda SR, Wong TY, Zeraatkar D, Ma J, Garg SJ, Munk MR, Borrelli E, Steel DH, Sivaprasad S, Wykoff CC, Chaudhary V
doi: 10.1016/j.survophthal.2025.08.016
Macular DiseasesRetinal Diseases
Faricimab Treat-and-Extend Dosing for Macular Edema due to Retinal Vein Occlusion: 72-Week Results From the BALATON and COMINO Trials
Ophthalmol Retina
Danzig CJ, Dinah C, Ghanchi F, Hattenbach LO, Khanani AM, Lai TYY, Shimura M, Abreu F, Arrisi P, Liu Y, Paris LP, Retiere AC, Willis JR, Schlottmann PG, BALATON and COMINO Investigators
doi: 10.1016/j.oret.2025.03.005
Retinal Diseases
Intravenous alteplase versus oral aspirin for acute central retinal artery occlusion within 4·5 h of severe vision loss (THEIA): a multicentre, double-dummy, patient-blinded and assessor-blinded, randomised, controlled, phase 3 trial
Lancet Neurol
Préterre C, Gaultier A, Obadia M, Vignal C, Mourand I, Plat J, Sablot D, Gaudron M, Rodier G, Godeneche G, Urbanczyk C, Marc G, Massardier E, Adam S, Boulanger M, Marcel S, Mechtouff L, Ronzière T, Calvière L, Godard-Ducceschi S, Barbin L, Lebranchu P, Guillon B, THEIA collaborators
doi: 10.1016/S1474-4422(25)00308-4
Retinal Diseases
Clinical characteristics associated with complications and poor visual outcomes in ocular toxoplasmosis: Analysis of 853 patients: complications and visual outcomes in ocular toxoplasmosis
Am J Ophthalmol
de-la-Torre A, Mejía-Salgado G, Cifuentes-González C, Cuevas M, García S, Rangel CM, Durán C, Pachón-Suárez DI, Bustamante-Arias A, Rojas-Carabali W
doi: 10.1016/j.ajo.2025.02.027